Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan L French

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|November 1, 2011
Extending the latent variable model for extra correlated longitudinal dichotomous responsesMatthew M Hutmacher, Jonathan L French
Biostatistics (Oxford, England)|April 1, 2004
Generalized additive models for cancer mapping with incomplete covariatesJonathan L French, Matthew P Wand
Journal of Pharmacokinetics and Pharmacodynamics|April 2, 2010
Longitudinal aggregate data model-based meta-analysis with NONMEM: approaches to handling within treatment arm correlationJae Eun Ahn, Jonathan L French
Biometrics|December 24, 2002
Bayesian methods for a three-state model for rodent carcinogenicity studiesJonathan L French, Joseph G Ibrahim
Statistics in Medicine|February 4, 2014
A linearization approach for the model-based analysis of combined aggregate and individual patient dataPatanjali Ravva, Mats O Karlsson, Jonathan L French
CPT: Pharmacometrics & Systems Pharmacology|November 20, 2023
Confounded exposure metricsMatthew R Wiens, Jonathan L French, James A Rogers
Statistics in Medicine|April 8, 2011
Estimating transformations for repeated measures modeling of continuous bounded outcome dataMatthew M Hutmacher, Jonathan L French, Sriram Krishnaswami, et al.
Journal of Clinical Pharmacology|October 1, 2010
Missing data in model-based pharmacometric applications: points to considerMarc R Gastonguay, Jonathan L French, Daniel F Heitjan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 2, 2007
Central nervous system pharmacokinetics of the Mdr1 P-glycoprotein substrate CP-615,003: intersite differences and implications for human receptor occupancy projections from cerebrospinal fluid exposuresKarthik Venkatakrishnan, Elaine Tseng, Frederick R Nelson, et al.
Plos One|December 3, 2020
Complex genetic dependencies among growth and neurological phenotypes in healthy children: Towards deciphering developmental mechanismsLisa Uechi, Mahjoubeh Jalali, Jayson D Wilbur, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Pharmacokinetics and Pharmacodynamics|November 1, 2011
Extending the latent variable model for extra correlated longitudinal dichotomous responsesMatthew M Hutmacher, Jonathan L French
Biostatistics (Oxford, England)|April 1, 2004
Generalized additive models for cancer mapping with incomplete covariatesJonathan L French, Matthew P Wand
Journal of Pharmacokinetics and Pharmacodynamics|April 2, 2010
Longitudinal aggregate data model-based meta-analysis with NONMEM: approaches to handling within treatment arm correlationJae Eun Ahn, Jonathan L French
Biometrics|December 24, 2002
Bayesian methods for a three-state model for rodent carcinogenicity studiesJonathan L French, Joseph G Ibrahim
Statistics in Medicine|February 4, 2014
A linearization approach for the model-based analysis of combined aggregate and individual patient dataPatanjali Ravva, Mats O Karlsson, Jonathan L French
CPT: Pharmacometrics & Systems Pharmacology|November 20, 2023
Confounded exposure metricsMatthew R Wiens, Jonathan L French, James A Rogers
Statistics in Medicine|April 8, 2011
Estimating transformations for repeated measures modeling of continuous bounded outcome dataMatthew M Hutmacher, Jonathan L French, Sriram Krishnaswami, et al.
Journal of Clinical Pharmacology|October 1, 2010
Missing data in model-based pharmacometric applications: points to considerMarc R Gastonguay, Jonathan L French, Daniel F Heitjan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 2, 2007
Central nervous system pharmacokinetics of the Mdr1 P-glycoprotein substrate CP-615,003: intersite differences and implications for human receptor occupancy projections from cerebrospinal fluid exposuresKarthik Venkatakrishnan, Elaine Tseng, Frederick R Nelson, et al.
Plos One|December 3, 2020
Complex genetic dependencies among growth and neurological phenotypes in healthy children: Towards deciphering developmental mechanismsLisa Uechi, Mahjoubeh Jalali, Jayson D Wilbur, et al.
Pageof 2